Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

01 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

03 Aug 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Jul 2015 Wright Reports 55 $75.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

16 Jun 2015 GlobalData 34 $125.00

MOSL: AUROBINDO PHARMA (Buy) - Strong operational growth led by US business

AUROBINDO PHARMA 4QFY15: Strong operational growth led by US business (ARBP IN, Mkt Cap USD6.1b, CMP INR1375, TP INR1645, 20...

01 Jun 2015 Motilal Oswal Securities Ltd. 12 $115.00

Aurobindo Pharma (ARBP) - Qtr. Update - Dated - May 30, 2015

Aurobindo Pharma (Bloomberg: ARBP IN, BUY, TP: Rs 1,550; 13% upside from CMP of Rs 1,375) While ARBP’s Q4 revenue (+35% Yo...

01 Jun 2015 Axis Capital Limited 8 $81.00

Aurobindo Pharma Ltd.| Q4FY15 Result/Concall Update | Key drivers for superior growth in earnings remains intact; we raise our price target to Rs1,600 from Rs1,412 earlier and maintain BUY rating on the stock

Aurobindo Pharma Ltd.| Q4FY15 Result/Concall Update Key drivers for superior growth in earnings remains intact; we raise our...

30 May 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

Aurobindo Pharma Ltd.| Q4FY15 First Cut Analysis | Operating margins improves sequentially; maintain BUY rating on the stock with price target of Rs1,412

Aurobindo Pharma Ltd.| Q4FY15 First Cut Analysis | Operating margins improves sequentially; maintain BUY rating on the stock ...

29 May 2015 IndiaNivesh Securities Pvt Ltd 4 $35.00

Company Snapshot - Aurobindo Pharma Limited

A director at Aurobindo Pharma Limited sold 75,000 shares at 1,338.100INR and the significance rating of the trade was 86/100...

14 Apr 2015 Directors Deals Ltd. 1 $12.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

17 Mar 2015 GlobalData 33 $125.00